Announced Tue, 11 Aug · 22:03 IST
New CEO appointed, three independent directors added, weak Q1 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹39.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.6+1.0+0.4-1.8-7.1-4.6+0.8———
Up moveDown movePending
AI summary
Board approved Q1 FY27 results with total income of Rs 870.46 lakhs against Rs 891.88 lakhs in Q1 FY26, posting a marginal net profit of Rs 0.28 lakhs and EPS of Rs 0.00. Full year FY26 loss was Rs 111.72 lakhs. Dr Thanigai Vendan Moorrthy was appointed CEO in non-director capacity for five years. Three new independent directors were also appointed and the Audit Committee and Stakeholders Relationship Committee were reconstituted.
Likely market impact
Leadership refresh with new CEO and independent directors may strengthen governance, but near break-even quarterly results show the hospital remains under financial pressure.